Glucose Response in Persons with Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Other: Oral nutrition supplement - testOther: Oral nutrition supplement - control
- Registration Number
- NCT04914559
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
This will be a randomized crossover design with oral nutrition supplement interventions.
- Detailed Description
This will be a randomized crossover design with two oral nutrition supplement interventions. The subjects will be randomized to one of two interventions on two separate study days, one week apart.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- Age 20-75 years
- Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
- Hemoglobin A1C less than 9.0%
- Fasting blood glucose less than 180 mg/dl
- Hematocrit levels within normal limits
- Having obtained his/her informed consent
Exclusion Criteria
- Abnormal thyroid function
- Creatinine >2.0 mg/dl
- Potassium <3.5 mEq/l
- Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
- Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
- Patients with anemia
- Current insulin therapy or insulin therapy within the past month
- Patient who are pregnant
- Allergies to milk, soy or any component of the test product
- Patient who in the investigators assessment cannot be expected to comply with treatment
- Patients with anemia
- Currently participating in another clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Oral Nutrition Supplement Test Oral nutrition supplement - test The test study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition for people living with diabetes. Oral Nutrition Supplement Control Oral nutrition supplement - control The control study intervention is an oral drink that contain protein, carbohydrate and fat and are intended for use as supplemental nutrition.
- Primary Outcome Measures
Name Time Method Area under the blood glucose curve Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes Area under the blood glucose curve (AUC 0-240 minutes)
- Secondary Outcome Measures
Name Time Method Insulinogenic index Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes Insulinogenic index (change in Ins30/change in Glu30)
Area under the insulin curve Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes Area under the insulin curve (AUC 0-240 minutes)
Trial Locations
- Locations (1)
Orange County Research Center
🇺🇸Tustin, California, United States